MPharma : our take on rising interest rates
Inside the numbers: what it means for operators building in $Nairobi.
MPharma : our take on rising interest rates
- The practical move an operator can make this quarter.
- How Egypt's market shapes the outcome.
- The real cost behind the seed round.
Inside the numbers: what it means for operators building in $Nairobi.
- The practical move an operator can make this quarter.
- How Egypt's market shapes the outcome.
- The real cost behind the seed round.
For anyone building in news & opinion, the useful question is where this changes your costs, distribution or competition — and how soon you act on it.
AI-generated summary. It can miss nuance — read the full story above for the complete picture.
mPharma has moved again — and for founders across Egypt, the details matter more than the headline.
Backers including Tiger Global are wagering that a checkout SDK can win where telco wallets have stalled.
Why it matters
Capital buys time; execution buys the market.
For most founders, the lesson isn't the raise — it's the discipline around runway that made it possible.
Competitors won't sit still. Expect telco wallets to respond within the quarter.
What to watch next
- Whether mPharma can hold margins while it chases 40% MoM growth.
- Which rivals move first, and how telco wallets counter.
- How the a checkout SDK performs outside the launch market.
The bet is placed. The market will settle it soon enough.
